| Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats. | |
| | |
MedLine Citation:
|
PMID: 20836700 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Betacellulin (BTC), a ligand of the epidermal growth factor receptor, has been shown to promote growth and differentiation of pancreatic β-cells and to improve glucose metabolism in experimental diabetic rodent models. Mesenchymal stem cells (MSCs) have been already proved to be multipotent. Recent work has attributed to rat and human MSCs the potential to differentiate into insulin-secreting cells. Our goal was to transfect rat MSCs with a plasmid containing BTC cDNA to guide MSC differentiation into insulin-producing cells. Prior to induction of cell MSC transfection, MSCs were characterized by flow cytometry and the ability to in vitro differentiate into mesoderm cell types was evaluated. After rat MSC characterization, these cells were electroporated with a plasmid containing BTC cDNA. Transfected cells were cultivated in Dulbecco's modified Eagle medium high glucose (H-DMEM) with 10 mM nicotinamide. Then, the capability of MSC-BTC to produce insulin in vitro and in vivo was evaluated. It was possible to demonstrate by radioimmunoassay analysis that 10(4) MSC-BTC cells produced up to 0.4 ng/mL of insulin, whereas MSCs transfected with the empty vector (negative control) produced no detectable insulin levels. Moreover, MSC-BTC were positive for insulin in immunohistochemistry assay. In parallel, the expression of pancreatic marker genes was demonstrated by molecular analysis of MSC-BTC. Further, when MSC-BTC were transplanted to streptozotocin diabetic rats, BTC-transfected cells ameliorated hyperglycemia from over 500 to about 200 mg/dL at 35 days post-cell transplantation. In this way, our results clearly demonstrate that BTC overabundance enhances glucose-induced insulin secretion in MSCs in vitro as well as in vivo. |
| | |
Authors:
|
Ana H Paz; Gabrielle Dias Salton; Ana Ayala-Lugo; Cristiano Gomes; Paula Terraciano; Rosana Scalco; Claudia Cilene Fernandes Correia Laurino; Eduardo Pandolfi Passos; Marlon R Schneider; Luise Meurer; Elizabeth Cirne-Lima |
Publication Detail:
|
Type: Journal Article Date: 2010-10-26 |
Journal Detail:
|
Title: Stem cells and development Volume: 20 ISSN: 1557-8534 ISO Abbreviation: Stem Cells Dev. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-01-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101197107 Medline TA: Stem Cells Dev Country: United States |
Other Details:
|
Languages: eng Pagination: 223-32 Citation Subset: IM |
Affiliation:
|
1 Laboratorio de Embriologia e Diferenciagao Celular, Centro de Pesquisas UFRGS-HCPA , Porto Alegre, Brazil . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Advanced rescuer- versus citizen-witnessed cardiac arrest: Is there a difference in outcome?
Next Document: Evaluation and Optimization of the Administration of Recombinant Adeno-Associated Viral Vectors (Ser...